Cat lane / iStockphoto.com
Pharmaceutical company Sanofi has announced it is investing €170 million ($202 million) to expand an influenza vaccine production facility in France.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Sanofi, influenza, pharmaceutical, VaxigripTetra , vaccine, flu